CVS GROUP PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,064 GBX | -0.19% |
|
+2.70% | -36.78% |
| May. 23 | CVS Group says will back investigation by UK CMA into pet market | AN |
| May. 23 | CVS Group Signals Cooperation for UK Watchdog's Investigation into Veterinary Sector | MT |
Valuation
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 509.5 | 728.2 | 1,710 | 1,178 | 1,413 | 764.5 | - | - |
| Enterprise Value (EV) 1 | 611.5 | 888.9 | 1,859 | 1,318 | 1,591 | 983.5 | 938.9 | 885.9 |
| P/E ratio | 62.4 x | 127 x | 89.1 x | 46.1 x | 33.8 x | 17.8 x | 15.6 x | 13.2 x |
| Yield | 0.76% | - | 0.27% | 0.42% | 0.38% | 0.74% | 0.79% | 0.85% |
| Capitalization / Revenue | 1.25 x | 1.7 x | 3.35 x | 2.13 x | 2.32 x | 1.14 x | 1.06 x | 1.01 x |
| EV / Revenue | 1.5 x | 2.08 x | 3.64 x | 2.38 x | 2.62 x | 1.47 x | 1.31 x | 1.17 x |
| EV / EBITDA | 11.2 x | 12.5 x | 19.1 x | 12.3 x | 13.1 x | 7.58 x | 6.71 x | 5.93 x |
| EV / FCF | 21.5 x | 13.6 x | 42.6 x | 25.8 x | 41 x | 20.7 x | 15.8 x | 13.1 x |
| FCF Yield | 4.66% | 7.34% | 2.34% | 3.87% | 2.44% | 4.84% | 6.33% | 7.6% |
| Price to Book | 3.13 x | 4.36 x | 8.93 x | 5.4 x | 5.5 x | 2.57 x | 2.3 x | 1.98 x |
| Nbr of stocks (in thousands) | 70,419 | 70,695 | 70,820 | 71,120 | 71,424 | 71,721 | - | - |
| Reference price 2 | 7.235 | 10.30 | 24.15 | 16.56 | 19.79 | 10.66 | 10.66 | 10.66 |
| Announcement Date | 9/27/19 | 9/24/20 | 9/23/21 | 9/22/22 | 9/21/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 406.5 | 427.8 | 510.1 | 554.2 | 608.3 | 670.9 | 719.3 | 759.4 |
| EBITDA 1 | 54.5 | 71 | 97.5 | 107.4 | 121.4 | 129.8 | 140 | 149.3 |
| EBIT 1 | 45.3 | 46.8 | 73.2 | 82.3 | 93.8 | 100.4 | 107.6 | 115 |
| Operating Margin | 11.14% | 10.94% | 14.35% | 14.85% | 15.42% | 14.96% | 14.96% | 15.14% |
| Earnings before Tax (EBT) 1 | 11.7 | 9.9 | 33.1 | 36 | 53.9 | 65.12 | 71.25 | 82.41 |
| Net income 1 | 8.2 | 5.7 | 19.3 | 25.7 | 41.9 | 45.07 | 48.07 | 57.94 |
| Net margin | 2.02% | 1.33% | 3.78% | 4.64% | 6.89% | 6.72% | 6.68% | 7.63% |
| EPS 2 | 0.1160 | 0.0810 | 0.2710 | 0.3590 | 0.5850 | 0.5995 | 0.6847 | 0.8052 |
| Free Cash Flow 1 | 28.5 | 65.2 | 43.6 | 51 | 38.8 | 47.59 | 59.39 | 67.37 |
| FCF margin | 7.01% | 15.24% | 8.55% | 9.2% | 6.38% | 7.09% | 8.26% | 8.87% |
| FCF Conversion (EBITDA) | 52.29% | 91.83% | 44.72% | 47.49% | 31.96% | 36.68% | 42.42% | 45.11% |
| FCF Conversion (Net income) | 347.56% | 1,143.86% | 225.91% | 198.44% | 92.6% | 105.61% | 123.54% | 116.26% |
| Dividend per Share 2 | 0.0550 | - | 0.0650 | 0.0700 | 0.0750 | 0.0790 | 0.0845 | 0.0901 |
| Announcement Date | 9/27/19 | 9/24/20 | 9/23/21 | 9/22/22 | 9/21/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2021 S1 | 2021 S2 | 2023 S1 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|
| Net sales 1 | 245.6 | 264.5 | - | - | 362.8 |
| EBITDA 1 | 45.1 | 52.4 | 57.8 | - | 68.9 |
| EBIT 1 | 33.3 | 39.9 | - | - | 53 |
| Operating Margin | 13.56% | 15.09% | - | - | 14.61% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | - | - | - | 14.6 | - |
| Net margin | - | - | - | - | - |
| EPS | - | - | - | 0.2040 | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/25/21 | 9/23/21 | 2/24/23 | 2/29/24 | - |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 102 | 161 | 149 | 140 | 178 | 219 | 174 | 121 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.872 x | 2.263 x | 1.528 x | 1.302 x | 1.463 x | 1.688 x | 1.246 x | 0.8126 x |
| Free Cash Flow 1 | 28.5 | 65.2 | 43.6 | 51 | 38.8 | 47.6 | 59.4 | 67.4 |
| ROE (net income / shareholders' equity) | 20.5% | 18% | 10.8% | 12.6% | 17.7% | 14.8% | 15.9% | 15.8% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | 7.21% | 7.99% | 8.2% |
| Assets 1 | - | - | - | - | - | 625.1 | 602 | 706.3 |
| Book Value Per Share 2 | 2.310 | 2.360 | 2.700 | 3.070 | 3.600 | 4.150 | 4.640 | 5.380 |
| Cash Flow per Share 2 | 0.5900 | 1.100 | 0.8500 | 1.060 | 1.180 | 1.210 | 1.350 | 1.430 |
| Capex 1 | 12.9 | 12.4 | 16.6 | 24.5 | 45.7 | 40.5 | 39.3 | 38.5 |
| Capex / Sales | 3.17% | 2.9% | 3.25% | 4.42% | 7.51% | 6.04% | 5.46% | 5.07% |
| Announcement Date | 9/27/19 | 9/24/20 | 9/23/21 | 9/22/22 | 9/21/23 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
10.66
GBP
Average target price
16.51
GBP
Spread / Average Target
+54.89%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.78% | 977M | |
| -13.34% | 170M |
- Stock Market
- Equities
- CVSG Stock
- Financials CVS Group plc
